BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32700577)

  • 1. Midterm Fate of the Contralateral Foot in Charcot Arthropathy.
    Waibel FWA; Berli MC; Gratwohl V; Sairanen K; Kaiser D; Shin L; Armstrong DG; Schöni M
    Foot Ankle Int; 2020 Oct; 41(10):1181-1189. PubMed ID: 32700577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after protected full weightbearing treatment in an orthopedic device in diabetic neuropathic arthropathy (Charcot arthropathy): a comparison of unilaterally and bilaterally affected patients.
    Renner N; Wirth SH; Osterhoff G; Böni T; Berli M
    BMC Musculoskelet Disord; 2016 Dec; 17(1):504. PubMed ID: 28031030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Diabetic Charcot Patients With and Without Foot Wounds.
    Wukich DK; Sadoskas D; Vaudreuil NJ; Fourman M
    Foot Ankle Int; 2017 Feb; 38(2):140-148. PubMed ID: 27923212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of conservative treatment of Charcot feet.
    Gratwohl V; Jentzsch T; Schöni M; Kaiser D; Berli MC; Böni T; Waibel FWA
    Arch Orthop Trauma Surg; 2022 Oct; 142(10):2553-2566. PubMed ID: 33829302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Difference in Risk of Amputation or Frequency of Surgical Interventions Between Patients With Diabetic and Nondiabetic Charcot Arthropathy.
    Waibel FWA; Weber S; Selman F; Götschi T; Berli MC; Böni T; Schöni M
    Clin Orthop Relat Res; 2023 Aug; 481(8):1560-1568. PubMed ID: 36692512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midfoot Charcot Neuro-arthropathy Precipitated by First or Fifth ray Amputation.
    Fontalis A; Doorgakant A; Zahra W; Blundell C
    Foot Ankle Surg; 2021 Aug; 27(6):673-676. PubMed ID: 33132011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.
    Sohn MW; Stuck RM; Pinzur M; Lee TA; Budiman-Mak E
    Diabetes Care; 2010 Jan; 33(1):98-100. PubMed ID: 19825822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction.
    Elmarsafi T; Anghel EL; Sinkin J; Cooper PS; Steinberg JS; Evans KK; Kim PJ; Attinger CE
    J Foot Ankle Surg; 2019 Mar; 58(2):295-300. PubMed ID: 30850098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Scoring System for Patients Undergoing Reconstructive Foot and Ankle Surgery for Charcot Neuroarthropathy: The Charcot Reconstruction Preoperative Prognostic Score.
    Rettedal D; Parker A; Popchak A; Burns PR
    J Foot Ankle Surg; 2018; 57(3):451-455. PubMed ID: 29574036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ostectomy and Medial Plantar Artery Flap Reconstruction for Charcot Foot Ulceration Involving the Midfoot.
    Sato T; Ichioka S
    J Foot Ankle Surg; 2016; 55(3):628-32. PubMed ID: 26190780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midfoot Charcot Neuroarthropathy in Patients With Diabetes: The Impact of Foot Ulceration on Self-Reported Quality of Life.
    Raspovic KM; Hobizal KB; Rosario BL; Wukich DK
    Foot Ankle Spec; 2015 Aug; 8(4):255-9. PubMed ID: 25956872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in Asian Indians with Charcot's neuroarthropathy: a nested cohort prospective study.
    Chaudhary S; Bhansali A; Rastogi A
    Acta Diabetol; 2019 Dec; 56(12):1259-1264. PubMed ID: 31187250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Incidence of Recurrent Ulceration and Major Amputations Associated With Charcot Foot.
    Nilsen FA; Molund M; Hvaal KH
    J Foot Ankle Surg; 2018; 57(2):301-304. PubMed ID: 29310882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications from ankle arthrodesis in diabetes-related Charcot foot syndrome.
    Wang BK; Wukich DK; Sambandam S
    J Diabetes Complications; 2021 Dec; 35(12):108071. PubMed ID: 34674895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization for Charcot neuroarthropathy in diabetes: A population study in Italy.
    Anichini R; Policardo L; Lombardo FL; Salutini E; Tedeschi A; Viti S; Francia P; Brocco E; Maggini M; Seghieri G; De Bellis A
    Diabetes Res Clin Pract; 2017 Jul; 129():25-31. PubMed ID: 28500867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming.
    Ford SE; Cohen BE; Davis WH; Jones CP
    Foot Ankle Int; 2019 Jan; 40(1):18-23. PubMed ID: 30284492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Patient Setting and Dedicated Limb Salvage Efforts on Outcomes in Charcot-Related Foot Ulcer.
    Schmidt BM; Holmes CM
    Int J Low Extrem Wounds; 2019 Dec; 18(4):362-366. PubMed ID: 31304814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic charcot neuroarthropathy of the foot and ankle with osteomyelitis.
    Ramanujam CL; Stapleton JJ; Zgonis T
    Clin Podiatr Med Surg; 2014 Oct; 31(4):487-92. PubMed ID: 25281510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].
    Kučera T; Grinac M; Valtr O; Šponer P
    Acta Chir Orthop Traumatol Cech; 2019; 86(1):51-57. PubMed ID: 30843514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment for chronic Charcot neuroarthropathy.
    Galli M; Scavone G; Vitiello R; Flex A; Caputo S; Pitocco D
    Foot (Edinb); 2018 Sep; 36():59-66. PubMed ID: 30368193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.